Not applicableEnded earlyNCT02778412What this trial is testingCtDNA in Patients With Thyroid NodulesWho this might be right forThyroid CancerThyroid NodulesThyroid Adenoma+1 more Pathway Genomics 66
Not applicableUnknownNCT03090815What this trial is testingCirculating Tumor DNA (ctDNA) as a Prognostic Tool in Patients With Advanced Lung AdenocarcinomaWho this might be right forAdenocarcinoma of Lung (Disorder) The University of Hong Kong 100
Not applicableActive Not RecruitingNCT04574635What this trial is testingHuman Papilloma Virus (HPV) Circulating Tumor DNA (ctDNA) in Cervical CancerWho this might be right forCervical Adenosquamous CarcinomaCervical Squamous Cell Carcinoma, Not Otherwise SpecifiedInfiltrating Cervical Carcinoma+24 more Mayo Clinic 18
Not applicableLooking for participantsNCT07026240What this trial is testingPost-operative Monitoring of Gastric CancerWho this might be right forGastric Cancer Suzhou Huhu Health & Technology Inc. 258
Testing effectiveness (Phase 2)Looking for participantsNCT05420948What this trial is testingPembrolizumab in Combination With Chemotherapy for Head and Neck CancerWho this might be right forHead and Neck CancerHead and Neck Squamous Cell CarcinomaHead and Neck Neoplasms+2 more University of Chicago 30
Testing effectiveness (Phase 2)Looking for participantsNCT06070012What this trial is testingTebentafusp in HLA-A*0201 Positive Previously Untreated Metastatic Uveal MelanomaWho this might be right forUveal Melanoma Diwakar Davar 44
Not applicableUnknownNCT03381326What this trial is testingCTC, Free DNA, Stem Cells and EMT-related Antigens as Biomarkers of Activity of Cabazitaxel in CRPC.Who this might be right forProstate CancerMetastatic CancerCastration-resistant Prostate Cancer+1 more Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 104
Not applicableLooking for participantsNCT06588322What this trial is testingDetection of Homologous Recombination Pathway Gene Mutations in Circulating Tumour DNA From BRCA-mutated Ovarian Cancer Patients Receiving First-line PARP Inhibitor Maintenance TherapyWho this might be right forOvarian Cancer Institut Claudius Regaud 130
Not applicableLooking for participantsNCT06231953What this trial is testingA Prospective, Multi-center Clinical Study to Establish Multi-Cancer Early Detection Platform Through the Analysis of Whole Genome Sequencing of Circulating DNA in Cancer Patients and Healthy VolunteersWho this might be right forInvasive CancerHealthy Volunteer Yonsei University 4,000
Large-scale testing (Phase 3)Active Not RecruitingNCT06939439What this trial is testingUsing ctDNA to Guide Treatment Decisions for Stage III Gastric CancerWho this might be right forGastric Cancer Stage III The First Affiliated Hospital with Nanjing Medical University 416
Not applicableLooking for participantsNCT06717243What this trial is testingGenomic and Methylation Markers in SCLC and LCNEC for Chemo-Immunotherapy Resistance Prediction (STRATUS)Who this might be right forSmall Cell Lung CancerLarge Cell Neuroendocrine (NE) TumorsTreatment Failure+3 more Oncology Center of Biochemical Education And Research 111
Not applicableStudy completedNCT04763148What this trial is testingTumor Heterogeneity in Diffuse Large B-cell Lymphoma in Relation to CNS Involvement and Cell-free DNAWho this might be right forLymphoma, Large B-Cell, Diffuse Herlev Hospital 26
Not applicableUnknownNCT05969938What this trial is testingPredicting the Efficacy and Prognosis of Rectal Cancer Patients Based on ctDNA-MRD TechnologyWho this might be right forRectal AdenocarcinomaCirculating Tumor DNAMinimal Residual Disease+1 more WeiWei Xiao 50
Not applicableActive Not RecruitingNCT06744075What this trial is testingStudy of the Clearance of Minimal Residual Disease Measured at the End of First-line Treatment in Patients With LymphomaWho this might be right forB-cell LymphomaHodgkin Lymphoma Centre Henri Becquerel 108
Not applicableLooking for participantsNCT06958107What this trial is testingLCI-SAR-BSTS-CTDNA-001: Circulating Tumor DNA Liquid Biopsy in Sarcoma PatientsWho this might be right forSarcoma Wake Forest University Health Sciences 300
Not applicableUnknownNCT05167604What this trial is testingClinical Value of MRD Monitoring for Adjuvant Therapy in Postoperative NSCLCWho this might be right forCarcinoma, Non-Small-Cell LungNext-Generation SequencingChemotherapy, Adjuvant+2 more Tang-Du Hospital 150
Testing effectiveness (Phase 2)Looking for participantsNCT07150247What this trial is testingSafety and Efficacy of IB-FOLFIRI in BRAF V600E-Mutant Metastatic Colorectal CancerWho this might be right forBRAF V600 Colorectal Cancer Sun Yat-sen University 20
Not applicableLooking for participantsNCT05952661What this trial is testingMinimally Residual of Esophageal Cancer 001Who this might be right forEsophageal CarcinomaMinimal Residual Disease Hebei Medical University Fourth Hospital 56
Not applicableUnknownNCT03878537What this trial is testingRecurrence Monitoring in NSCLC Using Circulating Tumor DNAWho this might be right forNon Small Cell Lung Cancer Scripps Translational Science Institute 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07069595What this trial is testingPREDICT-RD: ctDNA Surveillance in TNBC With Residual DiseaseWho this might be right forBreast CancerResidual DiseaseTriple Negative Breast Cancer (TNBC)+1 more UNC Lineberger Comprehensive Cancer Center 78